Skip to main content
. Author manuscript; available in PMC: 2013 Jul 12.
Published in final edited form as: J Med Chem. 2012 Jun 29;55(13):6061–6075. doi: 10.1021/jm300171v

Figure 3.

Figure 3

Effects of the analogs on the mobility rate of BVDV E2 protein in western blot assay. MDBK cells were infected with BVDV at an MOI of 1 for 1 hour followed by mock-treatment or treatment with indicated compounds at concentrations of 0.8, 4.0, 20 or 100 μM, respectively. Cells were harvested at 22 hour post infection and aliquots of cell lysates were analyzed by electrophoresis followed by western blotting to simultaneously detect BVDV E2 glycoprotein (green), and β-actin (red). Arrow heads indicated E2 protein with slower mobility rate.